These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32053549)

  • 1. Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry.
    Zhang M; Moore GA; Chin PKL
    Ther Drug Monit; 2020 Jun; 42(3):473-480. PubMed ID: 32053549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).
    Noguez JH; Ritchie JC
    Methods Mol Biol; 2016; 1383():21-7. PubMed ID: 26660170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
    Lagoutte-Renosi J; Le Poupon J; Girard A; Montange D; Davani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():43-49. PubMed ID: 30292948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-analyte analysis of non-vitamin K antagonist oral anticoagulants in human plasma using tandem mass spectrometry.
    Blaich C; Müller C; Michels G; Wiesen MH
    Clin Chem Lab Med; 2015 Nov; 53(12):1981-90. PubMed ID: 25901716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
    Gous T; Couchman L; Patel JP; Paradzai C; Arya R; Flanagan RJ
    Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.
    Wiesen MHJ; Blaich C; Streichert T; Michels G; Müller C
    Clin Chem Lab Med; 2017 Aug; 55(9):1349-1359. PubMed ID: 28328524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays.
    Kuhn J; Gripp T; Flieder T; Dittrich M; Hendig D; Busse J; Knabbe C; Birschmann I
    PLoS One; 2015; 10(12):e0145478. PubMed ID: 26699714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
    Lindahl S; Dyrkorn R; Spigset O; Hegstad S
    Ther Drug Monit; 2018 Jun; 40(3):369-376. PubMed ID: 29578938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.
    Baldelli S; Cattaneo D; Pignatelli P; Perrone V; Pastori D; Radice S; Violi F; Clementi E
    Bioanalysis; 2016 Feb; 8(4):275-83. PubMed ID: 26808218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an ultra-high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of direct oral anticoagulants in human plasma.
    Zhang YF; Liu XQ; Wang Y; Xu X; Zhong MK; Zhang P; Ma CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122952. PubMed ID: 34598085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L; Lukes J; Friedecky D; Zhanelova M; Nemcova M; Ulehlova J; Prochazkova J; Hlusi A; Palova M; Vaclavik J
    Clin Lab; 2018 Oct; 64(10):1611-1621. PubMed ID: 30336535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.
    Bluecher A; Meyer Dos Santos S; Ferreirós N; Labocha S; Meyer Dos Santos IM; Picard-Willems B; Harder S; Singer OC
    Thromb Haemost; 2017 Feb; 117(3):519-528. PubMed ID: 28124061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays.
    Kuhn J; Gripp T; Flieder T; Hammerschmidt A; Hendig D; Faust I; Knabbe C; Birschmann I
    Clin Chim Acta; 2018 Nov; 486():347-356. PubMed ID: 30114406
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography-Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma.
    Zhang M; Moore GA; Chin PKL; Everts R; Begg EJ
    Ther Drug Monit; 2018 Dec; 40(6):682-692. PubMed ID: 30015652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum.
    Boehr S; Haen E
    Ther Drug Monit; 2017 Feb; 39(1):66-76. PubMed ID: 27861316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.
    Gouin-Thibault I; Freyburger G; de Maistre E; Susen S; Delavenne X; Golmard JL; Gruel Y; Sié P;
    Thromb Res; 2017 Oct; 158():126-133. PubMed ID: 28892657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.
    Yamazaki-Nishioka M; Kogiku M; Noda M; Endo S; Takekawa M; Kishi H; Ota M; Notsu Y; Shimizu M; Yamazaki H
    Xenobiotica; 2019 Sep; 49(9):1001-1006. PubMed ID: 30216091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma.
    Letertre LR; Gudmundsdottir BR; Francis CW; Gosselin RC; Skeppholm M; Malmstrom RE; Moll S; Hawes E; Francart S; Onundarson PT
    J Thromb Haemost; 2016 May; 14(5):1043-53. PubMed ID: 26924677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study.
    Delavenne X; Mismetti P; Basset T
    J Pharm Biomed Anal; 2013 May; 78-79():150-3. PubMed ID: 23499913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.